🔎 Trials Near Me

Akèy › Kansè pwostat › Wisconsin

Etid klinik pou Kansè pwostat nan Wisconsin

47 etid pou Kansè pwostat ap chèche patisipan nan sit nan Wisconsin.

Vil nan Wisconsin

Tèks ofisyèl etid la (Anglè)

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of Wisconsin Carbone Cancer Center, Madison
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
  • ak 25 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

  • Froedtert Menomonee Falls Hospital, Menomonee Falls
  • Medical College of Wisconsin, Milwaukee
  • Froedtert and MCW Moorland Reserve Health Center, New Berlin
  • ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT07200830

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • ThedaCare Regional Cancer Center, Appleton
  • ThedaCare Regional Medical Center - Appleton, Appleton
  • ak 50 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

  • Marshfield Medical Center-Marshfield, Marshfield
  • Froedtert Menomonee Falls Hospital, Menomonee Falls
  • Medical College of Wisconsin, Milwaukee
  • ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977

PET/CT Characterization of Treatment Resistance

  • University of Wisconsin, Madison
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Oct 1, 2026 · NCT05647564

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Duluth Clinic Ashland, Ashland
  • Aurora Cancer Care-Southern Lakes VLCC, Burlington
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • ak 25 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  • Medical College of Wisconsin ( Site 0020), Milwaukee
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06136650

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07028853

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277

High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT05011383

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT04038502

A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)

  • University Hospital and UW Health Clinics ( Site 0065), Madison
  • Medical College of Wisconsin ( Site 0008), Milwaukee
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT06925737

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

  • Carbone Cancer Center University of Wisconsin-Madison, Madison
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 15, 2026 · NCT06150417

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • University of Wisconsin, Madison
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 11, 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Langlade Hospital and Cancer Center, Antigo
  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • ak 36 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

  • Froedtert & the Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 9, 2026 · NCT07226713

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

  • UW Health Carbone Cancer Center, Madison
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07005154

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Zablocki Veterans Administration Medical Center, Milwaukee
Ap rekriteVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

  • Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06582017

COMPASS Study for Metastatic Castration-resistant Prostate Cancer

  • University of Wisconsin Carbone Cancer Center, Madison
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Aug 27, 2026 · NCT07050433

A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

  • University of Wisconsin Carbone Cancer Center-Madison, Madison
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT06844383

Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial

  • Froedtert Hospital, Milwaukee
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT07227077

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • University of Wisconsin Carbone Cancer Center - Johnson Creek, Johnson Creek
  • ak 13 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • University of Wisconsin, Carbone Cancer Center, Madison
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

  • University of Wisconsin Carbone Cancer Center, Madison
  • Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1
Laj 18 a 100 · Gason · Mizajou Aug 13, 2026 · NCT05519449

Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer

  • University of Wisconsin-Madison, Madison
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Gason · Mizajou Aug 12, 2026 · NCT04489719

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

  • Medical College of Wisconsin, Milwaukee
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 31, 2026 · NCT06613100

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

  • Mayo Clinic Health System-Eau Claire, Eau Claire
  • Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jul 30, 2026 · NCT06325046

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Duluth Clinic Ashland, Ashland
  • Northwest Wisconsin Cancer Center, Ashland
  • Marshfield Medical Center-EC Cancer Center, Eau Claire
  • ak 10 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924

Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells

  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT05691465

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

  • University of Wisconsin, Madison
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 9, 2026 · NCT07103018

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • University of Wisconsin Carbone Cancer Center, Madison
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 9, 2026 · NCT05413421

Integrated Cancer Repository for Cancer Research

  • Bellin Memorial Hospital, Green Bay
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 110 · Tout sèks · Mizajou Jun 29, 2026 · NCT02012699

Using FAPI PET/MRI to Evaluate Prostate Cancer

  • University of Wisconsin, Madison
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06675357

International Registry for Men With Advanced Prostate Cancer (IRONMAN)

  • University of Wisconsin Carbone Cancer Center, Madison
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou May 22, 2026 · NCT03151629

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

  • William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
  • Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee
Ap rekriteFaz 2/3
Laj 18 ak plis · Gason · Mizajou Apr 8, 2026 · NCT04787744

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

  • University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Mar 20, 2026 · NCT06705686

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

  • University of Wisconsin - Madison, Madison
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Mar 11, 2026 · NCT07090148

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.